Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-12-05
1996-08-06
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544153, A61K 31535, C07D41312
Patent
active
055434088
ABSTRACT:
The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.
REFERENCES:
patent: 4328213 (1982-05-01), Ecker et al.
patent: 4478829 (1984-10-01), Landaburu et al.
patent: 4753935 (1988-06-01), Nelson et al.
patent: 4786637 (1988-11-01), Allison et al.
Fleitman Jeffrey S.
Fu Roger C.
Leung De-Mei
Miksztal Andrew R.
Rizzolio Michele C.
Ramsuer Robert W.
Syntex (U.S.A.) Inc.
LandOfFree
Crystalline anhydrous mycophenolate mofetil and intravenous form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline anhydrous mycophenolate mofetil and intravenous form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline anhydrous mycophenolate mofetil and intravenous form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191218